| Application no. and date | 21151194.4 (espacenet) (Federated) (European Patent Register), 20181018 | | Patent/reg. no. and date | DK/EP 3858333, 20251126 | | Publication date | 20210804 | | Priority no. and date | US 201762574965 P, 20171020 | | EP pub. no. and date |
EP 3858333 20210804 | | Effective date | | | Applicant/owner | BioNTech SE, An der Goldgrube 12
55131 Mainz, DE | | Applicant ref. no. | V2601-018-DK | | Inventor | HAAS, Heinrich, c/o BioNTech SE
An der Goldgrube 12
55131 Mainz, DE,
HÖRNER, Sebastian, c/o BioNTech SE
An der Goldgrube 12
55131 Mainz, DE,
ESPARZA BORQUEZ, Isaac Hernan, c/o BioNTech SE
An der Goldgrube 12
55131 Mainz, DE,
HILLER, Thomas Michael, c/o BioNTech SE
An der Goldgrube 12
55131 Mainz, DE,
BATES, Ferdia, c/o BioNTech SE
An der Goldgrube 12
55131 Mainz, DE | | Representative | NORDIC PATENT SERVICE A/S, Bredgade 30, 1260 København K | | Opponent | | | IPC Class | A61K 31/713 (2006.01) , A61K 47/26 (2006.01) , A61K 9/08 (2006.01) , A61K 9/127 (2025.01) | | Title | FREMSTILLING OG OPBEVARING AF LIPOSOMALE RNA-FORMULERINGER, DER ER EGNEDE TIL TERAPI | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
